secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orchestra BioMed Holdings, Inc. (OBIO)
CIK:        0001814114
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0001213900-23-005022
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Sciences Acquisitions 2 shareholders approve merger with Orchestra BioMed; closing expected Jan 2023
--------------------------------------------------------------------------------

- All 9 proposals approved at Jan 24 EGM, including Merger Agreement, Domestication, and Equity Incentive Plan.
- Business Combination with Orchestra BioMed to close in January 2023, subject to remaining conditions.
- Directors elected for New Orchestra: Eric Rose, Jason Aryeh, Pamela Connealy, Geoffrey Smith, David Hochman, Darren Sherman, Eric Fain.
- Vote results: 9.44M for (96.5% of voting) on Business Combination Proposal; quorum of 87.2% achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814114/000121390023005022/0001213900-23-005022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814114/000121390023005022/ea172160-8k425_health2.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-005022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer